-
Swarmer Promotes Garrett Kasper to CCO, Realigns Duties Among Executives
July 24, 2026 19:00 ET | Source: Swarmer AUSTIN, Texas, July 24, 2026 (GLOBE NEWSWIRE) — Swarmer, Inc (Nasdaq: SWMR) (“Swarmer” or the “Company”), a drone autonomy software company whose technology has supported more than 100,000 real-world combat missions in Ukraine since April 2024, today announced a promotion and realignment of duties among its executive…
-
ARCPOINT PROVIDES LEADERSHIP UPDATE
July 24, 2026 19:34 ET | Source: ARCpoint Inc. GREENVILLE, South Carolina, July 24, 2026 (GLOBE NEWSWIRE) — ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) announces today that Peter Kendall has stepped down as Interim Chief Executive Officer of the Company, having completed his mandate and delivered his assessment and recommendations to the Board…
-
Major shareholder announcement
Company announcement No. 44/2026 24 July 2026 Major shareholder announcement Netcompany Group A/S (“Netcompany”) hereby announces the following notification received pursuant to section 38, 39, and 40 of the Danish Capital Markets Act from The Goldman Sachs Group, Inc, regarding their direct and indirect holdings and voting rights in Netcompany. On 23 July 2026, The…
-
Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering
July 23, 2026 21:08 ET | Source: Scribe Therapeutics Inc. ALAMEDA, Calif., July 23, 2026 (GLOBE NEWSWIRE) — Scribe Therapeutics Inc. (“Scribe Therapeutics”) (Nasdaq: SCTX), a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend healthy lifespan through disease prevention and durable therapeutic intervention, today announced the pricing of its upsized initial…
-
Sword Group | Q2 2026 Results
Consolidated Revenue: €97.0mOrganic Growth (i): +13.7%Profitability (EBITDA Margin): 12.0%(i) on a like-for-like basis and at constant exchange rates KEY FIGURESThe consolidated revenue for the second quarter of 2026 amounted to €97.0 million, representing an increase of 13.7% at constant scope and exchange rates compared with the second quarter of 2025.Profitability (EBITDA margin) reached 12.0%, corresponding…
-
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc
Group sales were +6% at constant exchange rates (CER)1, -2% when reported in CHF and +8% in USD2, in the first six months, driven by high demand for innovative medicines and diagnostics. Pharmaceuticals Division sales were +6% at CER, -1% when reported in CHF and +8% in USD, due to continued high growth in sales…
-
Healx Announces First Patient Dosed in Phase 1/2 Trial to Evaluate the Effect of HLX-4310 on Metastatic Recurrence and Progression in Sarcomas with a Focus on Osteosarcoma
July 22, 2026 02:00 ET | Source: Healx Cambridge, UK – 22 July, 2026 – Healx, an AI-powered, clinical-stage biotech company dedicated to rare diseases, today announced that the first patient has been dosed in its Phase 1/2 dose-escalation and dose-confirmation clinical trial to evaluate the safety and efficacy of HLX-4310, an investigational oral combination…
-
Allogenetics Appoints Dr. Jeroen Rovers as Chief Medical Officer
Seasoned executive leader and physician-scientist brings deep immunology and transplant medicine experience Company strengthens executive team as it advances its lead ex vivo donor-organ therapy ALG-115 toward clinical entry ALG-115 is designed to transform the treatment of graft rejection in lung transplantation Hanover, Germany, July 21, 2026 – Allogenetics today announced the appointment of Jeroen Rovers,…
-
Online Pokies Time Launches Independent Real-Money Testing Framework to Improve Transparency in Online Casino Reviews
Sydney, Australia, July 20, 2026 (GLOBE NEWSWIRE) — Online Pokies Time today announced the launch of its independent real-money casino testing framework, a long-term editorial initiative designed to improve transparency in how online casino reviews are researched, verified, and maintained for Australian players. The framework establishes a standardized evaluation process that the editorial team will…
-
VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan
ZURICH, SWITZERLAND – July 20, 2026 – VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA), an emerging leader in designing novel cancer therapies, today announced that it has received Scientific Advice from the German regulatory authority, the Paul-Ehrlich-Institute (PEI), regarding the underlying biology and proposed non-clinical development plan for its most-advanced development program based on its proprietary…
-
LeafTide Announces Weight Loss Supplement Launch Focused on Quality, Transparency, and Leaf Tide Consumer Education
Largo, FL, July 19, 2026 (GLOBE NEWSWIRE) — LeafTide today announced the introduction of a new dietary supplement as part of the company’s continued efforts to develop products within the broader wellness and nutrition category. The announcement reflects the company’s focus on responsible product development, clear communication, and providing consumers with accessible information about dietary supplements.…
-
Burntide Gummies Launch 2026 | Advanced Weight Loss Formula Highlights Ingredients, Supplement Facts Available in USA, UK, CA, By BurnTide.
New York City, July 19, 2026 (GLOBE NEWSWIRE) — In 2026, we are proud to announce the launch of Burntide, a truly effective natural gummy thoughtfully designed to support your weight loss journey while supporting your overall health and well-being. Burntide gummies combine a unique and powerful blend of premium, natural ingredients, carefully selected to…
-
iFLYTEK Launches GuideX, Taking Public Services from Answering Questions to Completing Tasks
SHANGHAI, July 18, 2026 (GLOBE NEWSWIRE) — iFLYTEK launched GuideX on Friday, an intelligent interaction agent for public service environments, at the World Artificial Intelligence Conference (WAIC) 2026. Conventional digital humans answer questions and stop there. GuideX is built to complete tasks, resting on three capabilities the company calls Omnimodal, Self-Regulation and Empathy-Driven. “iFLYTEK has…
-
Vireo Growth Inc. Completes Acquisition of Pennsylvania Dispensary License Transaction
MINNEAPOLIS, July 17, 2026 (GLOBE NEWSWIRE) — Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company”), today announced that it has completed its previously announced acquisition of all of the issued and outstanding limited liability company membership interests of FarmX, LLC d/b/a PhytoNatural (“PhytoNatural”), jointly with Vive Penn, LLC (“Vive”), a joint venture…
-
United Flow Technologies Expands Midwest Presence with Acquisition of Peterson and Matz
July 17, 2026 18:30 ET | Source: United Flow Technologies Irving, TX, July 17, 2026 (GLOBE NEWSWIRE) — United Flow Technologies (UFT), a leading technical distributor and solutions provider serving the municipal and industrial water and wastewater treatment markets and a portfolio company of Berkshire Partners, today announced the strategic acquisition of Peterson and Matz.…
-
Skyline LASIK Introduces WaveLight® Plus LASIK, Advancing Precision in Vision Correction
New data presented at the American Academy of Ophthalmology highlights enhanced visual outcomes with next-generation LASIK technology July 17, 2026 12:00 ET | Source: Skyline LASIK Colorado Springs, CO, July 17, 2026 (GLOBE NEWSWIRE) — Skyline LASIK is proud to announce the availability of WaveLight® Plus LASIK, an advanced, ray-tracing guided technology designed to deliver…
-
Altinteg Strengthens Compliance-Ready Traceability For Food Operations
Photo courtesy of Aliya Pogorelskaya FUNCHAL, Portugal, July 16, 2026 (GLOBE NEWSWIRE) — Altinteg Technology Solutions has strengthened its Traceability as a Service offering for food and regulated-product businesses, positioning the company’s end-to-end identification systems against tightening global regulatory frameworks. The company, founded and led by CEO Aliya Pogorelskaya, delivers integrated traceability systems combining RFID,…
-
Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases
CHICAGO, July 16, 2026 (GLOBE NEWSWIRE) — Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 250,000 shares of its common stock in the open market at an average price of approximately $0.2782 per share. The Company has now repurchased a…
-
GenOptima Launches Results-as-a-Service GEO Infrastructure to Help Enterprises Ensure Outcome in AI Search
SHANGHAI, July 16, 2026 (GLOBE NEWSWIRE) — GenOptima, an enterprise Generative Engine Optimization (GEO) infrastructure provider, announced the launch of its Results-as-a-Service (RaaS)-based GEO solution, designed to help organizations ensure outcome through measurable AI search visibility management as AI-powered search platforms continue to reshape how brands are discovered, interpreted, and recommended. GenOptima — Brand Consensus…
-
Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement
FREMONT, Calif., July 15, 2026 (GLOBE NEWSWIRE) — Spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the opening of a new innovation center in Bellevue, Washington, marking the relocation of its previous Seattle-area operations to a dedicated facility designed to support research and development (R&D) while strengthening collaboration and customer engagement. The…
-
Critical Pain Points for CIOs Explored in New Podcast Series
Cleveland, July 15, 2026 (GLOBE NEWSWIRE) — A new podcast series for IT leaders offering insightful commentary on the decisions shaping the future of enterprise technology launches next week. “The Savvy CIO,” hosted by former CIO Bradd Busick, and sponsored by Park Place Technologies, provides fresh insights from tech leaders qualified to unpack the tough calls…
-
Spire Healthcare announced as exclusive Team GB Official Healthcare Services Partner
Organisations join forces for “a healthier, more productive nation” Agreement with Team GB covers the Los Angeles 2028 Olympic Games LONDON, July 15, 2026 (GLOBE NEWSWIRE) — Spire Healthcare today announces a new strategic partnership with Team GB, becoming the team’s exclusive Official Healthcare Services Partner through to the end of 2028, including the Los…
-
Lightspeed Introduces Lightspeed RevPay℠, a Connected Payments Experience Built for Today’s Dealerships
SALT LAKE CITY, July 14, 2026 (GLOBE NEWSWIRE) — Lightspeed, the leading provider of dealership management software for the Powersports, Marine, RV, Trailer, and Golf Car industries, today announced the launch of Lightspeed RevPay℠, a fully integrated payments experience built directly into Lightspeed DMS. For years, dealerships have relied on payment solutions designed for general…
-
Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain
July 13, 2026 20:35 ET | Source: Mesoblast Limited NEW YORK, July 13, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has achieved its target of at least 300 patients treated in the MSB-DR004 pivotal Phase 3 randomized controlled trial of rexlemestrocel-L…
-
Noble Capital Markets Initiates Equity Research Coverage on VivoPower
LONDON, UK / OSLO, NORWAY, July 13, 2026 (GLOBE NEWSWIRE) — VivoPower PLC (NASDAQ: VIVO) (“VivoPower” or the “Company”), a B Corp-certified global developer and owner of powered land and data center infrastructure for AI compute applications, is pleased to announce that Noble Capital Markets has initiated company-sponsored equity research coverage on the Company with…
-
LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer’s Disease Presented at the Alzheimer’s Association International Conference® (AAIC®) 2026
New clinical and real-world data support a subcutaneous treatment pathway from initiation through maintenance treatment, offering dosing convenience for patients and care partners July 12, 2026 11:18 ET | Source: Biogen Inc. TOKYO and CAMBRIDGE, Mass., July 12, 2026 (GLOBE NEWSWIRE) — Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that new data…
-
Why Cannabis Dispensaries Are Investing in Commercial Cash-Handling Infrastructure
MIAMI, FL, July 12, 2026 (GLOBE NEWSWIRE) — A quiet shift is underway in how cannabis retailers handle cash. Where early operations improvised with basic counters and manual reconciliation, a growing number of high-volume dispensaries now invest in commercial cash-handling infrastructure: integrated counting, authentication, and reporting built to operate as a system. According to AccuBANKER,…
-
GuideAI Health Announces Marketing and Communications Programs
July 10, 2026 17:01 ET | Source: GuideAI Health Corp. BOSTON, July 10, 2026 (GLOBE NEWSWIRE) — GuideAI Health Corp. (Cboe CA: GDAI) (“GuideAI” or the “Company“) is pleased to announce that it has engaged Upswitch Media Corp. (“Upswitch”) and BTV-Business Television (“BTV”) — to execute a coordinated marketing, communications and investor-awareness program (the “Program”). The…
-
Horse Boost Gummies For Men 2026 Launch Featuring the Viral Horse Gelatin Salt Trick Recipe Male Enhancement Support By HorseBoost
New York City, July 11, 2026 (GLOBE NEWSWIRE) — In 2026, Horse Boost announces a new Gummies formula that takes a science-inspired approach to male health performance by focusing on a thoughtfully developed combination of ingredients commonly used in dietary supplements for supporting energy, vitality, stamina, circulation, stress management, and performance well-being. The formulation reflects…
-
What Separates Commercial Money Counters From Consumer Models?
MIAMI, FL, July 11, 2026 (GLOBE NEWSWIRE) — To a first-time buyer, a consumer money counter and a commercial one can look almost identical, and the consumer model is usually cheaper. According to AccuBANKER, a provider of commercial cash-handling solutions with more than 45 years of industry experience, the resemblance is superficial: the two categories…
-
Canadian Red Cross opens appeal to support people impacted by flooding in Manitoba
WINNIPEG, Manitoba, July 10, 2026 (GLOBE NEWSWIRE) — The Canadian Red Cross has launched the 2026 Manitoba Floods Appeal to provide support for those impacted by flooding in Manitoba. Donations to the Canadian Red Cross will be used to provide assistance to those impacted by the flooding in Manitoba with immediate and ongoing relief, recovery, and…
-
EX DeFi Introduces AI-Powered Trading Technology Amid Growing Adoption of Artificial Intelligence in Financial Markets
New York City, NY, July 10, 2026 (GLOBE NEWSWIRE) — Global financial markets continued to experience heightened attention from investors as market participants monitored economic data, corporate earnings, and developments in artificial intelligence (AI) technologies across industries. Major stock markets showed mixed but stable performance, with investors continuing to assess economic conditions, monetary policy expectations,…
-
No easy answers: European research consortia take on major challenges
COPENHAGEN, Denmark, July 10, 2026 (GLOBE NEWSWIRE) — Nine new Challenge Programme grants from the Novo Nordisk Foundation will support ambitious research across fungal diseases, cardiometabolic disease, soil health and non-equilibrium biological systems. With a European expansion, the 2026 awards unite strong research groups and diverse expertise across Europe in the pursuit of novel knowledge…
-
New Crypto: BNB Based AlphaPepe Nears Tier-1 Exchange Debut While Ethereum Price Prediction Targets $4000
MONACO, July 09, 2026 (GLOBE NEWSWIRE) — AlphaPepe is quickly becoming one of the new crypto names retail buyers are watching before the next public-market breakout. The BNB-based presale has now raised $1.95 million, crossed 10,000+ holders, and moved to a current price of $0.02095 while its presale window is closing soon. The timing is…
-
NTG Nordic Transport Group A/S – H1 2026 Conference Call
July 09, 2026 04:00 ET | Source: NTG Nordic Transport Group A/S NTG Nordic Transport Group A/S – H1 2026 Conference Call We expect to release the H1 2026 interim results of NTG Nordic Transport Group on the evening of August 10, 2026. A webcast and conference call will be held in the morning of…
-
Y-H2O Shines at Monaco Energy Boat Challenge, Enters Final Tuning on July
MONACO and SHENZHEN, China, July 09, 2026 (GLOBE NEWSWIRE) — The 13th Monaco Energy Boat Challenge officially kicked off with its Opening Ceremony on July 7. Shenzhen-based innovator Y-H2O, the only fully-fledged Chinese boat team, made a striking debut with its ‘Alaqua’ Y-3 model, drawing immediate and widespread attention, representing the Greater Bay Area to…
-
BiomX Signs Non-Binding Letter of Intent to Acquire Control of Revenue-Generating Security Infrastructure and Systems Integration Company, Expanding Its Security Platform with Critical Infrastructure and Secure-Site Integration Capabilities
Proposed acquisition of an Israeli company with approximately 20 years of operating experience is expected to strengthen BiomX’s Detection-Analysis-Response strategy through security systems, fire detection, access control, intrusion detection, building-control, electrical infrastructure and secure-site integration capabilities July 08, 2026 07:05 ET | Source: BiomX NETANYA, Israel, July 08, 2026 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE…
-
UK businesses drastically overestimate their AI progress
EXL’s 2026 UK Enterprise AI Study finds that while most companies think they’re ahead of the competition at AI, few actually see results at scale July 08, 2026 05:03 ET | Source: EXL 75% of companies believe they are ahead of their competitors on AI, but just 12% meet the criteria to qualify as an…
-
Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research
July 07, 2026 09:12 ET | Source: Alamar Biosciences, Inc. eMTBR-Tau offers a non-invasive, blood-based measurement of the tau tangle burden, the core pathology associated with disease progression and cognitive decline in Alzheimer’s disease Immunoassay for eMTBR-Tau is available in the NULISAseq™ Neuro 220 panel and as a single-plex assay through the Technology Access Program…
-
Scality and WEKA deepen partnership to accelerate enterprise AI adoption
SAN FRANCISCO, July 07, 2026 (GLOBE NEWSWIRE) — Scality, a global leader in data infrastructure software for the AI era, and WEKA, the data and memory infrastructure company, today announced an expanded partnership in France, anchored by a new joint customer support agreement. Under the agreement, Scality will distribute the companies’ joint solution to customers…
-
Zealand Pharma – Transactions related to share buy-back program (week 27, 2026)
Company announcement No. 31 / 2026 Zealand Pharma – Transactions related to share buy-back program (week 27, 2026) Copenhagen, Denmark, July 6, 2026 – Zealand Pharma A/S (“the Company” or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today reports transactions related to its share buy-back program (the…
-
JASIWAY Best-Selling Modern Sleeper Sofa Chair Launches on Wayfair, Bringing Flexible Small-Space Living to Modern American Homes
Sheridan, WY, July 04, 2026 (GLOBE NEWSWIRE) — JASIWAY, a modern furniture brand focused on flexible whole-home living solutions, announced that its best-selling Modern Sleeper Sofa Chair is now available on Wayfair, giving American consumers broader access to a compact, convertible furniture solution designed for today’s small-space homes, apartments, guest rooms, and hybrid living environments.…
-
Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program
HALIFAX, Nova Scotia, July 03, 2026 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases today announced that it has received a Notice of Termination for Convenience from the National Institute of Allergy and Infectious Diseases (“NIAID”), part of the…
-
Alarum Technologies Announces Temporary Operational Pause of Certain Network Services
July 04, 2026 13:09 ET | Source: Alarum Technologies Ltd. Tel Aviv, Israel, July 04, 2026 (GLOBE NEWSWIRE) — Alarum Technologies Ltd. (Nasdaq: ALAR, TASE: ALAR) (“Alarum” or the “Company”) today announced the following update. Further to the Company’s announcements dated July 2 and July 3, 2026, the Company continues to investigate the recent incident…
-
Mark Leeds, D.O. PA Launches FloridaTaper.com, a Free Educational Resource on Benzodiazepine Tapering, Withdrawal, and BIND
The new website from Mark Leeds, D.O. PA offers more than 60 physician-written articles, with new articles published daily, for patients, families, and clinicians navigating slow benzodiazepine dose reductions. July 03, 2026 18:58 ET | Source: Mark Leeds, DO PA Fort Lauderdale, FL, July 03, 2026 (GLOBE NEWSWIRE) — Mark Leeds, D.O. PA, a Florida…
-
Hostinger Introduces Coupon Code for First Time Users to Get 20% Off via HostVerify.co
July 03, 2026 15:58 ET | Source: HostVerify San Francisco, CA, July 03, 2026 (GLOBE NEWSWIRE) — Hostinger remains a premier choice for launching and managing websites globally. To help users minimize setup expenses, HostVerify.co has partnered with Hostinger to offer an exclusive 20% discount for first time users. When accessing Hostinger through the verified…
-
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
July 03, 2026 16:30 ET | Source: Teladoc Health, Inc. NEW YORK, July 03, 2026 (GLOBE NEWSWIRE) — Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee. Effective July 1, 2026, in connection with commencing employment as Head of Product of…
-
KTC Introduces H27E6, a 27-Inch WQHD 300Hz Monitor Built for Esports, Streaming, Creation, and Productivity
Houston, Texas, July 02, 2026 (GLOBE NEWSWIRE) — KTC, a professional display brand serving global gaming, creative, and productivity users, has introduced the KTC H27E6, a 27-inch WQHD Fast IPS monitor designed to meet the rising demand for high-refresh, multi-functional displays. Featuring a native 300Hz refresh rate, overclocking support up to 320Hz, professional-grade color accuracy,…
-
Jelly Force Male Enhancement Gummies Release Latest Formula for Men: JellyForce Unique Ingredient Profile Report
Pinellas Park, FL, July 02, 2026 (GLOBE NEWSWIRE) — These statements have not been evaluated by the Food and Drug Administration. JellyForce is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use, especially if currently taking prescription medications. JellyForce is a gummy dietary supplement formulated for men,…
-
Anoto Proposes New Corporate Identity as INQ Group AB
July 02, 2026 02:05 ET | Source: Anoto Group AB Anoto Group AB (publ) today announced that the Board of Directors will ask shareholders at the Company’s Annual General Meeting to approve changing the Company’s name to INQ Group AB (publ), reflecting its strategic transformation and aligning the listed company with its future-facing INQ brand. The…
-
GNI Group Completes Acquisition of AYUMI Pharmaceutical
TOKYO, July 01, 2026 (GLOBE NEWSWIRE) — GNI Group Ltd. (TSE: 2160, “GNI Group” or the “Company”) today announced that it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone. As a result, Ayumi Pharmaceutical Holdings Co., Ltd. and its subsidiary, Ayumi Pharmaceutical Co., Ltd. (“Ayumi…
-
Mesoblast Receives BLA Filing Number and Requests Modular Review for Rexlemestrocel-L in Patients with End-Stage Heart Failure and LVADs
June 30, 2026 20:38 ET | Source: Mesoblast Limited NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received a Biologics License Application (BLA) filing number from the U.S. Food and Drug Administration (FDA) and has requested a…
-
POET Technologies Recaps Highlights of CEO’s Update on Commercial Activities and Provides Results of 2026 AGM
TORONTO, June 30, 2026 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (NASDAQ: POET), the designer and developer of Photonic Integrated Circuits (PICs), light sources and optical modules for the AI and data center markets, today reported the voting results of its Annual General Meeting (the “AGM”), which was held virtually on Friday,…
-
Press Release: Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study
Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study Nexviazyme met its primary endpoint, participants alive and free of invasive ventilation, in treatment-naïve infants zero to six months of age in the Baby-COMET phase 3 study Sanofi intends to submit the data to support a regulatory application in the…
-
SVT Robotics Surpasses Four Billion Transactions on its SOFTBOT Platform
NORFOLK, Va., June 29, 2026 (GLOBE NEWSWIRE) — SVT Robotics, a leader in interoperability software that provides the data foundation for enterprise and physical AI, today announced that its SOFTBOT Platform has surpassed four billion transactions, underscoring the scale, resilience, and performance of the infrastructure it delivers worldwide. With transaction volumes now totaling 100 million…
-
Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations
Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopa Hopledo® is already approved and marketed in the United States as CREXONT®, providing established regulatory and commercial experience as the therapy advances toward European approval More than…
-
AiraBreeze Announces Entry into the Portable Cooling Products Industry with Introduction of Its First Consumer Cooling Solution
London, UK, June 28, 2026 (GLOBE NEWSWIRE) — AiraBreeze today announced its entry into the portable cooling products industry through the introduction of its first consumer cooling solution following the completion of its initial product development phase. The announcement marks the company’s transition from product design and development into commercial operations as it begins offering…
-
TBoostExperts.com Announces Availability of 2026 Consumer Report on Testosterone Booster Supplements and Men’s Health Supplement Evaluation
NEW YORK,USA, June 27, 2026 (GLOBE NEWSWIRE) — TBoostExperts.com today announced the availability of its 2026 Consumer Research Report on testosterone booster supplements and men’s health supplement evaluation, a newly published educational resource developed to help adult consumers better understand how to review supplement labels, ingredient disclosures, dosage transparency, product claims, and company information before…
-
HDFC ERGO Highlights the Importance of Comprehensive Car Insurance for Today’s Vehicle Owners
Mumbai, Maharashtra, June 27, 2026 (GLOBE NEWSWIRE) — Today’s vehicle owners face rising repair costs, accident risks, theft concerns, and unpredictable weather conditions that can lead to major financial stress. HDFC ERGO highlights the need for wider vehicle protection as owners look beyond basic compliance and focus on financial preparedness. While considering car insurance renewal online,…
-
Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results
LIKMEZ® (ATI-1501) commercial momentum building in U.S. market US$40 million NIAID award supporting VXV-01 advancement through Phase 1 HALIFAX, Nova Scotia, June 26, 2026 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced its financial and…
-
PrivacyHawk Launches Enterprise Service to Reduce Shadow Digital Footprint and Third-Party Breach Risk
LOS ANGELES, June 26, 2026 (GLOBE NEWSWIRE) — PrivacyHawk, the transparency-first data privacy company, today announced the general availability of PrivacyHawk Enterprise — a first-of-its-kind solution that identifies and eliminates the shadow IT accounts, abandoned SaaS subscriptions, and forgotten third-party services quietly exposing organizations to breach risk. Every organization has an invisible attack surface. Shadow…
-
Thought Leadership & Innovation Foundation Founder Bill Oldham Launches New Book: Beyond Better Data: What Actually Changes Health Care?
MCLEAN, Va., June 26, 2026 (GLOBE NEWSWIRE) — The Thought Leadership & Innovation Foundation (TLI) proudly announces the release of Beyond Better Data: What Actually Changes Health Care? a new book by Founder and Chairman Bill Oldham that brings together decades of experience in innovation, leadership, healthcare transformation, and the practical application of emerging technologies to…
-
Shoals Technologies Group Secures ITC Victory Upholding American Intellectual Property
PORTLAND, Tenn., June 25, 2026 (GLOBE NEWSWIRE) — Shoals Technologies Group, Inc. (“Shoals”) (Nasdaq: SHLS), a global leader in electrical infrastructure solutions for the energy transition market, announced a decisive victory in its patent infringement action against Voltage, LLC (“Voltage”) after the U.S. International Trade Commission affirmed the Administrative Law Judge’s (ALJ) ruling. The decision…
-
Commure Named “Overall NLP Company of the Year” in 2026 AI Breakthrough Awards
MOUNTAIN VIEW, Calif., June 25, 2026 (GLOBE NEWSWIRE) — Commure, a leading healthcare technology company, today announced it has been named “Overall NLP Company of the Year” in the 2026 AI Breakthrough Awards. The annual awards program recognizes the world’s most innovative companies, technologies, and products in artificial intelligence. Selected from more than 5,000 nominations…
-
Caseware Netherlands Launches Financial Reporting Visualization Agent Powered by Verity
APELDOORN, The Netherlands, June 25, 2026 (GLOBE NEWSWIRE) — Caseware, the leading AI platform for assurance and financial reporting, today announced it will launch its Financial Reporting Visualization Agent for the Netherlands market. The new AI-powered capability enables accounting and audit professionals to generate auditable financial charts and visualizations directly within Caseware engagements using natural…
-
The Developing Doctor Launches CME-Accredited Course to Enhance Physician Wellbeing
Iowa City, IOWA, June 24, 2026 (GLOBE NEWSWIRE) — The Developing Doctor has unveiled its latest self-paced course, “Mastery & Wellness: How to Thrive as a Physician,” now approved for 12 physician CME credits. This course is jointly provided with the Postgraduate Institute for Medicine (PIM), making it eligible for reimbursement through most institutional CME…
-
BNO Developments Makes Energy Class A Its Default Standard for Shortlisted Cyprus New-Builds
June 24, 2026 05:03 ET | Source: BNO Developments LIMASSOL, Cyprus, June 24, 2026 (GLOBE NEWSWIRE) — As energy efficiency shifts from a selling point to a resale necessity, the Cyprus specialist is building the standard into every shortlist it sends. BNO Developments announced that Energy Class A-rated properties will become the default standard for…
-
Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi)
– First patient dosed in a Phase 1 study evaluating ZM008, an anti-LLT1 mAb, in combination with LOQTORZI, a next-generation PD-1 inhibitor – June 23, 2026 14:00 ET | Source: Coherus Oncology, Inc. REDWOOD CITY, Calif., June 23, 2026 (GLOBE NEWSWIRE) — Coherus Oncology, Inc. (Nasdaq: CHRS) and Zumutor Biologics Inc. (“Zumutor”), an immuno-oncology biotech…
-
Regula Helps Uber Build a Nationwide Driver Verification Network in Poland
RESTON, Va., June 23, 2026 (GLOBE NEWSWIRE) — Regula is helping Uber bring advanced driver verification technologies to more cities across Poland. By expanding the use of Regula’s document authentication solutions nationwide, Uber is strengthening fraud prevention and adding an extra layer of high-assurance identity checks that goes beyond standard industry practices. As part of…
-
Dyne Therapeutics Appoints Barry Greene to Board of Directors
June 22, 2026 16:10 ET | Source: Dyne Therapeutics, Inc. WALTHAM, Mass., June 22, 2026 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the appointment of Barry Greene to its Board of Directors. Mr. Greene brings more…
-
Eva Live Targets Cybersecurity Aggressively, Standing Up an Internal Task Force to Meet AI Industry Needs
Through its Eva Defense subsidiary, Eva Live is forming a dedicated internal cybersecurity task force to move hard and fast on acquisitions and partnerships LAS VEGAS, NV, June 22, 2026 (GLOBE NEWSWIRE) — Eva Live Inc. (NASDAQ: GOAI) (“Eva Live” or the “Company”), a technology company focused on artificial intelligence and digital innovation, today announced…
-
MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026
Results from the Phase 3 VELA clinical trials at Week 52 in adults with moderate-to-severe hidradenitis suppurativa (HS) demonstrate sonelokimab’s (SLK) potential best-in-class and best-in-disease profile, with consistent responses that are higher than those observed in trials of competing agents at the end of their respective parental trials Namely, ~67% of patients treated with SLK…
-
Global Nexa Initiative Launches to Support Climate and Health Innovations
Global consortium seeks bold, scalable solutions that reduce climate-driven health harms on vulnerable communities June 21, 2026 13:30 ET | Source: Grand Challenges Canada LONDON, June 21, 2026 (GLOBE NEWSWIRE) — At London Climate Action Week, Grand Challenges Canada (GCC) and the Science for Africa Foundation (SFA Foundation) today announced the launch of Nexa, a global initiative to support locally led innovations that address the growing health impacts of…
-
JellyFil Publishes Updated 2026 Product Information for Its Premium Gummy Dietary Supplement, Including Full Ingredient List, Pricing, Refund Policy, and Customer Service Details
Largo, FL, June 20, 2026 (GLOBE NEWSWIRE) — These statements have not been evaluated by the U.S. Food and Drug Administration. JellyFil is not intended to diagnose, treat, cure, or prevent any disease. Consumers should consult a qualified healthcare professional before using any dietary supplement, particularly if currently taking prescription medications or managing existing health…
-
GARVEE Teams Up with TikTok Shop for Super Brand Day, Bringing Exclusive Limited-Time Deals Across Summer Cooling, Outdoor Living and Best-Selling Home Essentials
ONTARIO, Calif., June 20, 2026 (GLOBE NEWSWIRE) — GARVEE has announced its participation in TikTok Shop Super Brand Day from June 18 to July 2, 2026. During this limited-time shopping event, shoppers can explore a curated selection of summer cooling products, outdoor summer lifestyle essentials and top-performing TikTok Shop bestsellers through GARVEE’s official TikTok Shop…
-
BreathEaseX Publishes Updated 2026 Product Information for Its Oral Spray Dietary Supplement, Including Full Ingredient List, Pricing, Refund Policy, and Customer Service Details
AURORA, CO, June 19, 2026 (GLOBE NEWSWIRE) — These statements have not been evaluated by the U.S. Food and Drug Administration. BreathEaseX is not intended to diagnose, treat, cure, or prevent any disease. Consumers should consult a qualified healthcare professional before using any dietary supplement, particularly if currently taking prescription medications or managing existing health…
-
Altius Inspiro Secures Second Consecutive Fortress Cybersecurity Award for Network Security Excellence
MANILA, Philippines, June 20, 2026 (GLOBE NEWSWIRE) — Altius Inspiro, a global leader in digital customer experience (CX) and business process services (BPS), today announced it has won the prestigious 2026 Fortress Cybersecurity Award in the Network Security category from the Business Intelligence Group. Earning this distinction for the second consecutive year, the award highlights…
-
Desert Hope Treatment Center Launches First Responder Lifeline Program, Offering Confidential Care for Frontline Heroes
LAS VEGAS, June 18, 2026 (GLOBE NEWSWIRE) — Desert Hope Treatment Center, a leading addiction treatment center in Las Vegas, has introduced its First Responder Lifeline Program, designed specifically for law enforcement officers, firefighters, EMTs, dispatchers, corrections officers, and other public safety professionals. The program was developed in collaboration with public safety leaders, including representatives…
-
OVIOS Launches Fire Pit Conversation Collection Ahead of Father’s Day
LOS ANGELES, CA, June 18, 2026 (GLOBE NEWSWIRE) — As Father’s Day approaches, OVIOS has launched its Fire Pit Conversation Collection, a new outdoor furniture collection designed to help families create more comfortable, inviting, and experience-centered backyard spaces for celebrating dads. The launch comes as more American families are rethinking traditional Father’s Day gifting. Instead…
-
eimmigration Launches Heroes Spotlight to Recognize the Top Paralegals in Immigration Law
SAN DIEGO, June 17, 2026 (GLOBE NEWSWIRE) — eimmigration by Cerenade, the leading immigration case management software trusted by 17,000 legal professionals, today announced the launch of Heroes Spotlight: Top Paralegals in Immigration Law. The recognition program was unveiled at the American Immigration Lawyers Association (AILA) Annual Conference, where nominations officially opened. Nominations are open…
-
Nicox Announces Positive Pre-submission Regulatory Feedback in China Supporting NDA filing for NCX 470
Press Release Nicox Announces Positive Pre-submission Regulatory Feedback in China Supporting NDA filing for NCX 470 Exclusive licensee for China, Ocumension, received positive pre-submission regulatory feedback from the Chinese Center for Drug Evaluation (CDE) for NCX 470 Based on this feedback, Ocumension intends to proceed with the New Drug Application (NDA) submission in China Submission…
-
Atos joins CrowdStrike’s Project QuiltWorks to advance sovereign AI adoption and secure frontier AI risk
Press Release Atos joins CrowdStrike’s Project QuiltWorks to advance sovereign AI adoption and secure frontier AI risk Atos’ leadership at the intersection of cybersecurity, AI and digital sovereignty strengthens QuiltWorks’ ecosystem Paris, France – June 17, 2026 – Atos, a global leader of AI-powered digital transformation, today announces that it has joined CrowdStrike’s Project QuiltWorks.…
-
Resolution Therapeutics extends inflammatory and fibrotic disease pipeline with in vivo Regenerative Macrophage Therapy
Material Transfer Agreements provide access to leading lipid nanoparticle formulations to validate delivery of its proprietary payloads and accelerate development of in vivo Regenerative Macrophage Therapy Development programme complements Company’s autologous engineered Regenerative Macrophage Therapy, RTX001, in Ph 1/2 clinical development Together, programmes aim to broaden patient population able to benefit from Regenerative Macrophage Therapy…
-
Bond Announces Conversion of Outstanding Debt into Equity at Significant Premium to Market
June 16, 2026 08:07 ET | Source: Our Bond, Inc. Major Investor Exchanges Approximately $3.3 Million of Debt for Convertible Preferred Equity Priced at $2.0265 Per Common Share — a Premium of More Than 200% to Recent Trading Levels Above-Market Conversion Along With Separate Payment Schedule Adjustment Reduce 2026 Debt Burden By $4.3M, Reflecting Investors’…
-
Weston Family Foundation invests an additional $37 million to safeguard one of Canada’s most ecologically valuable and threatened ecosystems
The conservation initiative brings together Indigenous communities, ranchers, and conservation organizations to protect Canada’s critical prairie grasslands June 16, 2026 06:00 ET | Source: Weston Family Foundation TORONTO, June 16, 2026 (GLOBE NEWSWIRE) — The Weston Family Foundation just announced an additional $37 million in funding through the Weston Family Prairie Grasslands Initiative, strengthening and…
-
SoftServe Cuts AI Agent Deployment from Months to Four Weeks
New platform helps companies move AI agents out of test projects and into live operations, without building custom tools from scratch June 15, 2026 10:33 ET | Source: SoftServe, Inc AUSTIN, Texas, June 15, 2026 (GLOBE NEWSWIRE) — SoftServe, a digital engineering and technology services company, today released the SoftServe Agent Management Platform. It gives…
-
Orbs Launches On-Chain Execution Infrastructure for Institutional Crypto Trading
TEL AVIV, Israel, June 14, 2026 (GLOBE NEWSWIRE) — Orbs, the decentralized Layer-3 blockchain infrastructure focused on advanced on-chain trading, today announced Orbs Institutional, a new offering that provides trading desks, OTC firms, treasuries, custodians and financial platforms with direct access to its on-chain execution infrastructure. The launch builds on technology that has processed more…
-
Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026
– Verekitug, administered once every three months, led to clinically meaningful improvements in nasal polyp score (NPS) in approximately 80% of participants – – Majority of verekitug-treated participants experienced clinically meaningful improvements across key secondary endpoints, including 72% in nasal congestion and 83% in CRSwNP total symptom score – WALTHAM, Mass., June 14, 2026 (GLOBE…
-
Rocket Doctor Grants Stock Options and RSUs
June 12, 2026 17:13 ET | Source: Rocket Doctor AI Inc. Vancouver, BC, June 12, 2026 (GLOBE NEWSWIRE) — Rocket Doctor AI Inc. ( CSE: AIDR , OTC: AIRDF , Frankfurt: 939 ) (“Rocket Doctor AI”) has granted an aggregate 47,013 stock options, exercisable at $0.71 per share and valid for a term of three…
-
Exploratory Efficacy Data Suggests Further Study of Peanut Tolerance with Oral Mucosal Immunotherapy (OMIT)
NEW YORK, June 12, 2026 (GLOBE NEWSWIRE) — Intrommune Therapeutics, Inc., a clinical-stage biotechnology company committed to developing a patient-friendly treatment platform for people with peanut and other food allergies, today announced the presentation of exploratory efficacy data from the Oral Mucosal Escalation Goal Assessment (OMEGA) Phase 1 safety trial at the 2026 Eastern Allergy…
-
Nissan AMIEO Completes 180-Market Pricing Transformation with Syncron, Ahead of Schedule
STOCKHOLM, Sweden, June 11, 2026 (GLOBE NEWSWIRE) — Syncron, a global leader in intelligent aftermarket solutions, today announced that Nissan Africa, Middle East, India, Europe, & Oceania (AMIEO) has completed a full rollout of its parts pricing solution across 40 primary markets and more than 140 export markets, finishing ahead of schedule in Q1 2026…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.